Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
544.8 USD | +0.60% | -3.62% | +2.64% |
Apr. 17 | TD Cowen Raises Price Target on Thermo Fisher Scientific to $644 From $612 | MT |
Apr. 17 | HSBC Adjusts Thermo Fisher Scientific Price Target to $660 From $630 | MT |
Financials (USD)
Sales 2024 * | 43B | Sales 2025 * | 46.02B | Capitalization | 207B |
---|---|---|---|---|---|
Net income 2024 * | 6.34B | Net income 2025 * | 7.06B | EV / Sales 2024 * | 5.33 x |
Net Debt 2024 * | 22.52B | Net Debt 2025 * | 17.76B | EV / Sales 2025 * | 4.88 x |
P/E ratio 2024 * |
33.1
x | P/E ratio 2025 * |
28.7
x | Employees | 122,000 |
Yield 2024 * |
0.27% | Yield 2025 * |
0.3% | Free-Float | 87.14% |
Latest transcript on Thermo Fisher Scientific
1 day | +0.60% | ||
1 week | -3.62% | ||
Current month | -6.27% | ||
1 month | -6.51% | ||
3 months | -1.26% | ||
6 months | +15.99% | ||
Current year | +2.64% |
Managers | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 55 | 01-10-31 |
Director of Finance/CFO | 57 | 01-05-31 | |
Ryan Snyder
CTO | Chief Tech/Sci/R&D Officer | - | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Casper
CEO | Chief Executive Officer | 55 | 01-10-31 |
C. Harris
BRD | Director/Board Member | 67 | 12-03-29 |
Ruby Chandy
BRD | Director/Board Member | 62 | 22-02-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
11.69% | 2 M€ | -25.75% | ||
7.43% | 18 M€ | +1.40% | - | |
5.37% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 544.8 | +0.60% | 1,738,307 |
24-04-18 | 541.5 | -1.05% | 2,075,785 |
24-04-17 | 547.2 | -1.32% | 1,610,057 |
24-04-16 | 554.6 | -0.60% | 1,010,299 |
24-04-15 | 557.9 | -1.30% | 1,031,658 |
Delayed Quote Nyse, April 19, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.64% | 207B | |
+1.80% | 175B | |
+8.59% | 132B | |
+16.47% | 99.1B | |
-3.42% | 60.89B | |
+12.71% | 52.04B | |
-6.61% | 45.48B | |
-4.53% | 38.81B | |
+9.27% | 38.77B | |
+3.97% | 26.09B |
- Stock Market
- Equities
- TMO Stock